Literature DB >> 2953925

Uremic cardiomyopathy: an inadequate left ventricular hypertrophy.

G M London, F Fabiani, S J Marchais, M C de Vernejoul, A P Guerin, M E Safar, F Metivier, F Llach.   

Abstract

Echocardiographic study of the left ventricle was performed in 57 selected, normotensive hemodialysis patients in comparison to 40 healthy controls matched for sex, age and blood pressure. The statistically significant abnormalities in uremic patients were an enlargement of the left ventricular end-diastolic diameter (LVEDiD) (5.58 +/- 0.60 vs. 5.05 +/- 0.5 cm; P less than 0.001) and an increase in the left ventricular radius to posterior wall-thickness ratio (r/Th) (3.65 +/- 0.68 vs. 3.27 +/- 0.44; P less than 0.001). Enlargement of the ventricle was related to anemia (P less than 0.001) and the hemodynamic effect of arteriovenous fistula. Ventricular radius to wall thickness ratio was inversely related to systolic arterial pressure in controls (P less than 0.001) and patients (P less than 0.01) with a significant upward shift of the regression in dialysis patients (P less than 0.001). In dialysis patients, the left ventricular posterior wall thickness (LVPWT) was inversely correlated to serum parathormone (PTH) level (P less than 0.001), and r/Th ratio was positively correlated to serum PTH (P less than 0.001). Bone biopsy was performed in 28 patients. Histomorphometric indexes of osteitis fibrosa were in dialysis patients, correlated to echocardiographic abnormalities; osteoclasts number was inversely correlated to LVPWT (P less than 0.001) and positively related to r/Th ratio (P less than 0.001). Osteoclastic resorption surfaces and LVPWT were inversely correlated (P less than 0.001), while a positive correlation between r/Th ratio and osteoclastic resorption surfaces was observed (P less than 0.001). Osteoblastic surfaces and tetracycline double-labeled surfaces were also correlated to LVPWT (P less than 0.001) and r/Th ratio (P less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1987        PMID: 2953925     DOI: 10.1038/ki.1987.94

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  17 in total

Review 1.  Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.

Authors:  Xiaoliang Wang; Jiang Liu; Christopher A Drummond; Joseph I Shapiro
Journal:  Expert Opin Ther Targets       Date:  2017-04-03       Impact factor: 6.902

2.  The presence and impact of diastolic dysfunction on physical function and body composition in hemodialysis patients.

Authors:  Jin Hee Jeong; Pei-Tzu Wu; Brandon Michael Kistler; Peter John Fitschen; Annabel Guzman Biruete; Shane Aaron Phillips; Mohamed M Ali; Bo Fernhall; Kenneth Robert Wilund
Journal:  J Nephrol       Date:  2015-03-10       Impact factor: 3.902

Review 3.  The use of erythropoietin in renal failure.

Authors:  I C Macdougall; R D Hutton; G A Coles; J D Williams
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

4.  The relationship between R wave peak time and left ventricular mass index in patients with end-stage renal disease on hemodialysis.

Authors:  Macit Kalçık; Mucahit Yetim; Tolga Doğan; Barış Eser; İbrahim Doğan; Lütfü Bekar; Oğuzhan Çelik; Yusuf Karavelioğlu
Journal:  Int Urol Nephrol       Date:  2019-09-30       Impact factor: 2.370

5.  Echocardiography-based score to predict outcome after renal transplantation.

Authors:  Rajan Sharma; Eric Chemla; Maite Tome; Rajnikant L Mehta; Helen Gregson; Stephen J D Brecker; Rene Chang; Denis Pellerin
Journal:  Heart       Date:  2006-09-15       Impact factor: 5.994

Review 6.  Central and peripheral adaptations to physical training in patients with end-stage renal disease.

Authors:  E J Kouidi
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

7.  Improvement of left ventricular function after renal transplantation in a patient with uremic cardiomyopathy: report of a case.

Authors:  Y Okouchi; H Arisaka; A Shimada; K Miyamoto; S Takase; T Suzuki
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

8.  Reduction of Na/K-ATPase affects cardiac remodeling and increases c-kit cell abundance in partial nephrectomized mice.

Authors:  Christopher A Drummond; Moustafa Sayed; Kaleigh L Evans; Huilin Shi; Xiaoliang Wang; Steven T Haller; Jiang Liu; Christopher J Cooper; Zijian Xie; Joseph I Shapiro; Jiang Tian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-04-18       Impact factor: 4.733

9.  The effectiveness of renal transplantation as a treatment for recurrent uremic cardiomyopathy.

Authors:  Colin B Josephson; Diego Delgado; J Schiff; Heather Ross
Journal:  Can J Cardiol       Date:  2008-04       Impact factor: 5.223

Review 10.  Epoetin (recombinant human erythropoietin). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in anaemia and the stimulation of erythropoiesis.

Authors:  D Faulds; E M Sorkin
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.